Therefore, systemic inflammation and elevated levels of the Gal-9/TIM-3 may participate in the pathogenesis of RA-related NAFLD, as shown in the proposed model (Figure 5). This evidence concerns the gene LGALS9 and metabolic dysfunction-associated steatotic liver disease.